SAN DIEGO, Aug. 30 /PRNewswire/ — Aethlon Medical, Inc. (OTC
Bulletin Board:
AEMD), the pioneer in developing therapeutic filtration devices
to address infectious disease and cancer, announced today that its
Chairman and Chief Executive Officer, Jim Joyce, will present at
the Rodman & Renshaw Annual Global Investment Conference at
3:40 p.m. EDT on September 14, 2010. The event will be held at the
New York Palace Hotel in New York City from September 12-15, 2010.
Additional information can be accessed online at: http://www.rodmanandrenshaw.com.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
(Photo:
http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
Aethlon will be available for one-on-one meetings with investors
at the conference. To schedule one-on-one meetings with the Company
at this event or in the New York area, please call Jon Cunningham
at 407.644.4256, Ext. 107, or email
info@redchip.com.
About Aethlon MedicalAt Aethlon Medical, we create
revolutionary devices to address infectious disease and cancer. Our
devices are designed to be novel platform solutions that fill
therapeutic voids or aid in disease diagnosis and
monitoring.
Our Hemopurifier® is the first medical device to
selectively target the removal of infectious viruses and
immunosuppressive proteins from the entire circulatory system. We
recently discovered that our Hemopurifier® captures
tumor-secreted exosomes that suppress the immune system of those
afflicted with cancer. Prior to this discovery, a therapeutic
strategy to directly inhibit or reverse the immunosuppressive
destruction caused by exosomes did not exist in cancer care. By
eliminating this mechan
‘/>”/>
